-+ 0.00%
-+ 0.00%
-+ 0.00%

Karyopharm joins Cantor-hosted webcast featuring endometrial cancer KOL Robert Coleman

PUBT·06/03/2026 20:15:56
Listen to the news
Karyopharm joins Cantor-hosted webcast featuring endometrial cancer KOL Robert Coleman
  • Karyopharm will join a Cantor-hosted virtual fireside chat on June 8, 2026 at 12:00 p.m. ET.
  • Discussion will feature senior management alongside Robert Coleman, principal investigator of the Phase 3 XPORT-EC-042 endometrial cancer trial.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606031615PR_NEWS_USPR_____NE75351) on June 03, 2026, and is solely responsible for the information contained therein.